Critics caution that Robert F. Kennedy Jr.'s endorsement of unregulated peptide drugs contributes to a dangerous erosion of public health safeguards. Peptides sold without proper testing may carry unknown health risks, ranging from adverse side effects to dangerous drug interactions. Without oversight, there is no guarantee of product purity, dosage accuracy, or truthful marketing.
This "wild west" market undermines evidence-based medicine by promoting substances not vetted through rigorous clinical trials. Public figures like Kennedy hold significant influence, and their promotion of unproven treatments may encourage vulnerable individuals to forgo proven therapies or expose themselves to harm.
Regulatory agencies face an uphill battle trying to enforce safety standards online, where many peptide products are distributed. The resulting lack of control can lead to a growing public health risk, especially if widespread use increases before safety and efficacy are established.
Opponents argue that prioritizing speed and market freedom over careful scientific validation threatens trust in medical institutions and endangers consumers. They call for stronger regulatory frameworks and public education to counter misinformation and protect people from potentially harmful products aggressively marketed amid health uncertainties.